(1 reference)Quick Overview for Opioid Receptor, mu 1 (OPRM1) (AA 384-398) Peptide (ABIN2752006)
抗原
Mu Opioid Receptor 1 (OPRM1)
(Opioid Receptor, mu 1 (OPRM1))
应用范围
Blocking Peptide (BP), Control Peptide (CP)
-
-
蛋白结构域
- AA 384-398
-
原理
- MOR (Opioid Receptor-Mu) Peptide Control
-
产品特性
- The peptide control for Mu Opioid Receptor is intended for the immunoadsorption of Mu Opioid Receptor antiserum, ABIN617908. Preadsorption of Mu Opioid Receptor antiserum, diluted according to the antibody specification sheet, with 10µg/ml Mu Opioid Receptor peptide immunogen following the instructions below provides complete blockage of Mu Opioid Receptor immunolabeling. The peptide is provided as lyophilized rat Mu Opioid Receptor, sequence (384-398). Also, this antiserum contains ≤ 0.09% sodium azide.
-
纯化方法
- Purified
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstitute vial with 500 µl of PBS/Triton X-100 (0.05M sodium phosphate, 0.15M sodium chloride, 0.3% Triton X-100, pH 7.4), put the stopper back on and vortex lightly until dissolved.
-
储存液
- Sodium azide
-
储存方法
-
Prior to reconstitution, as described below, store at -15°C or lower.
After reconstitution, use immediately or refrigerate at 2°- 8°C. For long-term storage, aliquot and freeze at -15°C or lower. Avoid repeated freeze/thaw cycles.
-
-
-
: "Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury." in: European journal of pain (London, England), Vol. 15, Issue 7, pp. 669-75, (2011) (PubMed).
-
: "Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury." in: European journal of pain (London, England), Vol. 15, Issue 7, pp. 669-75, (2011) (PubMed).
-
- Mu Opioid Receptor 1 (OPRM1) (Opioid Receptor, mu 1 (OPRM1))
抗原
-
You are here:
